Perhaps best known for the Max Payne games of the early 2000s, Remedy has since developed Alan Wake and Quantum Break, though those were exclusive to Microsoft platforms. P7 is set to be made for a variety of contemporary systems, with 505 Games’ recent publishing deal netting it the rights to the property for the next 20 years and as much as a 45 percent share of net sale royalties.
The deal highlights that Project 7 will be a cinematic third-person action game set in a “new Remedy-created universe.” That suggests Remedy is sticking to its bread and butter, as all of its games bar a couple have been built in that perspective and with an action focus. We’re also told that the game will feature an “intriguing story,” and a game structure that will offer a long-lasting experience, with mechanics that are deeper than any Remedy game yet made.
It’s not entirely clear what that means, but one aspect that we can be a bit more certain on is that it will be made using the Northlight engine, the same one that Remedy used for Quantum Break. Here’s hoping it doesn’t suffer from the same texture glitch and performance issues.
“We have a strong vision of what P7 should be. 505 Games brings into this partnership experience and competencies that help us successfully make this vision become reality together,” said Remedy Entertainment CEO Tero Virtala.
“Remedy is also investing in P7 and is deeply committed to creating an unique gaming experience that will keep the players engaged and playing for a long time to come. We are really excited to embark on this journey with 505 Games.”
Although not discussed in this deal, Remedy is also working on a sequel to popular shooter Crossfire. The new game will be published by Korean firm Smilegate, and will be made exclusively available on Windows PCs.
Editors' Recommendations
- The best Xbox One exclusives
- The best Xbox One games for 2020
- The best PlayStation 4 games for 2020
- Every confirmed and rumored PS5 game so far
- Every confirmed and rumored Xbox Series X and Series S game so far
